CDMOs in Czechia: 4 compared (2026)
4 of the 255 contract development and manufacturing organisations in A4BEE’s European census are headquartered in Czechia. The largest, with revenue over €1bn, are Zentiva Group. 1 sit between €250m and €1bn and 2 are smaller or niche.
By ownership: 2 family-owned, 1 private equity and 1 state-owned. The most common capabilities are oral solid dose (2), sterile fill-finish (2), small-molecule API (1), biologics and biosimilars (1) and viral vector and vaccine (1). 2 of the 4 rows rest on audited reports or official company disclosures; the rest come from secondary sources or estimates.
4 companies
CDMOs in Czechia
| Company | HQ | Ownership | Size | Revenue (as reported) | Modalities | Data |
|---|---|---|---|---|---|---|
| Zentiva GroupLarge generics maker with an explicit B2B/CDMO arm (oral solids, sterile ampoules/vials, creams; APIs). Contract offering spans Prague and Bucharest. | Prague | Private equityAdvent International | Tier 1 | ~€1.3 bn (group est.) | Small-molecule API, Oral solid dose, Sterile fill-finish | high |
| BiovetaLargest Czech veterinary immunobiological/pharma maker; dedicated contract-manufacturing function (vaccines, antisera, sterile forms). Primarily veterinary. | Ivanovice na Hané | State-ownedCzech state (majority) | Tier 2 | not disclosed | Biologics and biosimilars, Viral vector and vaccine, Sterile fill-finish | medium |
| BioinovaGMP contract manufacturer of ATMPs — stem-cell/MSC therapies for clinical trials. Spin-off of the Czech Academy of Sciences. | Prague | Family-owned | Tier 3 | not disclosed | Cell and gene therapy | high |
| FaveaFamily-run CDMO for nutraceuticals plus human/veterinary solid dosage (tablets, capsules, pellets). Pharma scope modest vs. supplements. | Kopřivnice | Family-owned | Tier 3 | not disclosed | Oral solid dose | medium |
Size: Tier 1 (revenue over €1bn) · Tier 2 (€250m–€1bn) · Tier 3 (under €250m or niche).
Revenue, staff and site figures are as reported and mix audited accounts with commercial estimates, which are often wrong for private companies. Each row carries a confidence mark; verify a figure before quoting it.
Browse the census
Other European CDMO lists
By country
- CDMOs in Italy (31)
- CDMOs in Spain (30)
- CDMOs in Germany (28)
- CDMOs in the United Kingdom (25)
- CDMOs in France (15)
- CDMOs in Switzerland (14)
- CDMOs in Poland (11)
- CDMOs in Belgium (9)
- CDMOs in Sweden (9)
- CDMOs in Greece (8)
- CDMOs in Ireland (8)
- CDMOs in the Netherlands (8)
- CDMOs in Portugal (8)
- CDMOs in Denmark (7)
- CDMOs in Austria (5)
- CDMOs in Finland (5)
- CDMOs in Norway (5)
- CDMOs in Czechia
- CDMOs in Lithuania (4)
- CDMOs in Bulgaria (3)
By modality
- Small-molecule API CDMOs in Europe (107)
- Oral solid dose CDMOs in Europe (94)
- Sterile fill-finish CDMOs in Europe (106)
- Biologics and biosimilars CDMOs in Europe (66)
- Monoclonal antibody CDMOs in Europe (36)
- Antibody-drug conjugate (ADC) CDMOs in Europe (15)
- Cell and gene therapy CDMOs in Europe (29)
- mRNA and LNP CDMOs in Europe (22)
- Viral vector and vaccine CDMOs in Europe (32)
- Microbial and protein CDMOs in Europe (34)
- Peptide CDMOs in Europe (24)